Regenerx Biopharma buy melinda
Start price
01.11.10
/
50%
€0.13
Target price
02.05.11
€0.20
Performance (%)
-17.32%
End price
02.05.11
€0.11
Summary
This prediction ended on 02.05.11 with a price of €0.11. The prediction for Regenerx Biopharma disappointed with a performance of -17.32%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Regenerx Biopharma | - | - | - | - |
| iShares Core DAX® | 3.805% | 2.845% | 4.665% | 51.916% |
| iShares Nasdaq 100 | 1.292% | 10.824% | 38.356% | 101.883% |
| iShares Nikkei 225® | 2.013% | 7.857% | 50.986% | 67.501% |
| iShares S&P 500 | 0.987% | 5.921% | 27.296% | 72.810% |
Comments by melinda for this prediction
In the thread Regenerx Biopharma diskutieren
Biopharma-
regernerx Biopharma hat die Rechte der NIH, dass das Unternehmen seine Aufmerksamkeit auf ProtectOn und die Reparatur von Gewebe konzentrieren können erworben
(Laufzeit überschritten)


